Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 2:41 AM
Ignite Modification Date:
2025-12-26 @ 1:20 AM
NCT ID:
NCT02926833
Group ID:
EG003
Title:
Phase 2: KTE-C19 + ATZ (1 Day After KTE-C19)
Description:
Participants received conditioning chemotherapy consisting of 30 mg/m\^2 fludarabine and 500 mg/m\^2 cyclophosphamide IV infusion per day for 3 days followed by KTE-C19 IV infusion at a target dose of 2 x 10\^6 anti-CD19 CAR T cells/kg followed by 4 doses of ATZ (1200 mg/dose) IV infusion every 21 days, beginning 1 day following KTE-C19.
Deaths Number Affected:
14
Deaths Number At Risk:
None
Serious Number Affected:
15
Serious Number At Risk:
22
Other Number Affected:
22
Other Number At Risk:
22
Study:
NCT02926833
Results Section:
NCT02926833
Adverse Events Module:
NCT02926833